Skip to main content

Articles

Perspectives
Can We Make Medicines Affordable?
David B. Nash, MD, MBA
Read More
Original Research, Practice Management
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis After a Change in Targeted Therapy
Machaon M. K. Bonafede, PhD, MPH; Donna McMorrow, BS; Clare Proudfoot, PhD; Shraddha Shinde, MS, MBA; Andreas Kuznik, PhD; Chieh-I Chen, MPH
Read More
Original Research
Prior Authorization for Elective Diagnostic Catheterization: The Value of Reviewers in Cases with Clinical Ambiguity
Adam C. Powell, PhD; Stephen E. Price, DPT, MBA; Khoa Nguyen, MS; Gary L. Smith, MS; James W. Long, BSBA; Uday U. Deshmukh, MD, MPH
Stakeholder Perspective
Standardized Documentation Can Improve Diagnostic Testing Decisions for Patients with Cardiovascular Disease
Raymond L. Singer, MD, MMM, CPE, FACS
Read More
Conference Highlights AMCP
Can Technologic Innovations and Formulary Considerations Improve Healthcare Outcomes?
Charles Bankhead
Read More
Original Research
Long-Term Outcomes of a Cardiovascular and Diabetes Risk-Reduction Program Initiated by a Self-Insured Employer
Nicole D. White, PharmD, CDE; Thomas L. Lenz, PharmD, FACLM; Maryann Z. Skrabal, PharmD, CDE; Jessica J. Skradski, PharmD; Louis Lipari, PharmD candidate
Stakeholder Perspective
Influencing Patient Outcomes Through Enhanced Multidisease-Focused Interventions
Jack E. Fincham, PhD, RPh
Read More
FDA Approvals
Oncology Drugs Approved by the FDA in Early 2018
Read More
FDA Approvals
A “Gold Standard” for Population Health? Revisiting the FDA’s Relationship with the Hippocratic Oath
Read More
Original Research, Sleep, Practice Management
Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States
Kathleen F. Villa, MS; Nancy L. Reaven, MA; Susan E. Funk, MBA; Karen McGaughey, PhD; Jed Black, MD
Stakeholder Perspective
Accurate Diagnosis of Chronic Diseases Can Reduce Costs and Medical Resource Utilization
James T. Kenney, RPh, MBA
Read More
Original Research
Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry
Dimitrios A. Pappas, MD; Robert A. Gerber, PharmD; Heather J. Litman, PhD; David Gruben, PhD; Jamie Geier, PhD; Winnie D. Hua, MS; Connie Chen, PharmD; Youfu Li, MD, MPH; Joel M. Kremer, MD; John S. Andrews, MD; Jeffrey A. Bourret, PharmD
Stakeholder Perspective
Limited Guidelines and Treatment Success in the Current Standard of Care for Patients with Rheumatoid Arthritis Provide an Opportunity to Inform New Treatment Protocols
Gary Branning, MBA
Read More
Perspectives
Is Adequate Nutrition Cost-Effective?
David B. Nash, MD, MBA
Read More
Page 71 of 245
Results 701 - 710 of 2441